NDT and T3 use given support by US workers - Thyroid UK

Thyroid UK

141,183 members166,422 posts

NDT and T3 use given support by US workers

diogenes profile image
diogenesRemembering
15 Replies

This publication just out in Thyroid journal discusses using NDT (DTE) and T3 in suitable circumstances. It is I believe the opening of the door that has closed against NDT and T3 use, and in the future should encourage properly designed trials. They acknowledge the existence of a subset of patients who need these. Only have the abstract yet because it's behind a paywall, but am asking for full access which I'll pass on to TUK when I get it:

Thyroid Vol. 30, No. 10 Reviews and Scholarly Dialog

Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism

Thaer Idrees, Scott Palmer, Rui M.B. Maciel, and Antonio C. Bianco

Published Online:16 Oct 2020doi.org/10.1089/thy.2020.0153

Abstract

Background: The basis for the treatment of hypothyroidism with levothyroxine (LT4) is that humans activate T4 to triiodothyronine (T3). Thus, while normalizing serum thyrotropin (TSH), LT4 doses should also restore the body's reservoir of T3. However, there is evidence that T3 is not fully restored in LT4-treated patients.

Summary: For patients who remain symptomatic on LT4 therapy, clinical guidelines recommend, on a trial basis, therapy with LT4+LT3. Reducing the LT4 dose by 25 mcg/day and adding 2.5–7.5 mcg liothyronine (LT3) once or twice a day is an appropriate starting point. Transient episodes of hypertriiodothyroninemia with these doses of LT4 and LT3 are unlikely to go above the reference range and have not been associated with adverse drug reactions. Trials following almost a 1000 patients for almost 1 year indicate that similar to LT4, therapy with LT4+LT3 can restore euthyroidism while maintaining a normal serum TSH. An observational study of 400 patients with a mean follow-up of ∼9 years did not indicate increased mortality or morbidity risk due to cardiovascular disease, atrial fibrillation, or fractures after adjusting for age when compared with patients taking only LT4. Desiccated thyroid extract (DTE) is a form of combination therapy in which the LT4/LT3 ratio is ∼4:1; the mean daily dose of DTE needed to normalize serum TSH contains ∼11 mcg T3, but some patients may require higher doses. The DTE remains outside formal FDA oversight, and consistency of T4 and T3 contents is monitored by the manufacturers only.

Written by
diogenes profile image
diogenes
Remembering
To view profiles and participate in discussions please or .
Read more about...
15 Replies
Gingernut44 profile image
Gingernut44

Thanks for posting, let’s hope something will come of this

helvella profile image
helvellaAdministrator

I see the conclusion includes this:

A trial of combination therapy with LT4+LT3 can be considered for those patients who have unambiguously not benefited from LT4.

Concerning that they appear to demand no benefit from LT4. Not what we so often see, which is some, indeed sometimes considerable, benefit from LT4, but still having issues.

Might be that I am taking their words very literally. Probably too literally. But so too will at least some who read the paper and make decisions on treatment.

Musicmonkey profile image
Musicmonkey in reply tohelvella

helvella good point. Let's hope you are wrong. The study report is at least a little more encouraging than reports we usually see.

helvella profile image
helvellaAdministrator in reply toMusicmonkey

Afraid I all too often see the bad in bigger letters than the good!

Yes - at heart, it is VERY encouraging.

If only a company would produce a fully licenced desiccated thyroid product. One that is both very good quality and appreciated by those who get to take it. (This applies to all systems/countries - UK, USA, EU and everywhere else.)

TSH110 profile image
TSH110 in reply tohelvella

They’d make a small fortune.

m7-cola profile image
m7-cola in reply tohelvella

Yes, there will always be some medics who will choose to see reasons not to open their minds.

PaulRobinson profile image
PaulRobinson

Good news. Thank you for posting!

tattybogle profile image
tattybogle

Another crack in the dam :) ..... keep rolling the bouncing bombs

Nanaedake profile image
Nanaedake

Would be great to have options for everyone with lowish FT3 (even when in range) regardless of symptoms. I'm wondering what defines 'unambiguous'?

Gcart profile image
Gcart in reply toNanaedake

Yes unambiguous? can only be subjective in my opinion.

I have friends whom I think could benefit from something more than just Levo.

Still they think doc knows best , Dont mention now my improvement on addition of T3 . More importantly help that can be obtained on this site 👍😘

diogenes profile image
diogenesRemembering

They still lean on TSH being in the healthy reference range as a sign of proper therapy whether of T4, T3 or DTE. They cannot get over the different sensitivities of the pituitary and hypothalamus to larger T3 fractions in therapy as opposed to more T4 in health. Also we are honoured by their refusal to quote anything we write - even though it well predates this new awakening. That says it all.

Nanaedake profile image
Nanaedake in reply todiogenes

Keep writing is all I can say. It's often the lone voices willing to challenge the status quo that turn out to be right! After all, the NHS kept telling us different makes of levo in the UK were all bioequivalent but it turned out not to be so. There was a lone chemistry student who posted results of a dissolution test on the Internet show g that the tests used at that time were faulty. The student was right as it emerged.

jgelliss profile image
jgelliss

Diogenes you made me so very hopeful. I suffered for many years after my TT with high T4 dosages. I had palpitations since I'm not a good T4 to T3 converter . It literally debilitated me . After much begging and pleading with my then Endo he lowered my T4 and added 5 mcg T3 . It was a start for me . And I'm forever grateful for that.

I'm very excited that thyroid patients will now have new hope that they can be helped and dosed with the very much needed T3 the more active thyroid hormone without having to beg/plead to feel well.

Great and Hopeful News. Thank You.

Hillwoman profile image
Hillwoman

It's a chink of light, I suppose.

I'm afraid I've become more pessimistic about progress these days. When I still see so much advice on the forum that people who need T3 - especially in T3 monotherapy - must never dose to rise above the serum reference range, regardless of whether peripheral effects are sufficient, then I'm afraid there is still much education to be done among both professionals and patients.

penny profile image
penny in reply toHillwoman

I agree, Hillwoman. It is depressing at times to read the same sad stories repeated over and over again highlighting the ignorance of our medical professions on all things thyroid.

Not what you're looking for?

You may also like...

It's here at last: a comparison of T4, T4-T3 combination therapy and DTE (NDT) - fuel for using against sceptical doctors/endos

This is the abstract and conclusion from a brand new paper - not yet published in J Clin Endocrinol...
diogenes profile image
Remembering

Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism

Another interesting paper (and letters), supporting use of T3 - both synthetic and as desiccated...
helvella profile image
Administrator

Letter from Bianco's & Hoang's labs defending use of T3 and DTE in treatment

This letter is a reply to a rather critical one from Bonnema. It doesn't have a doi number so I've...
diogenes profile image
Remembering

Reply to queries on paper by Bianco et al

This is a reply to a group querying the validity of Bianco et al's paper on T4/T3 prefrence by some...
diogenes profile image
Remembering

Another study on T3 given to women with ongoing symptoms

This downloadable paper (I don't think I've posted this before, so apologies if I have) describes a...
diogenes profile image
Remembering